GrowLife Reports "An Up Quarter," Posts $1M In Backlog

GrowLife Inc. PHOT saw its revenue increase by 11% to $1.8 million during the second quarter.

According to a Monday’s update, the Kirkland, Washington-based cultivator has a gross margin of 39.3%, due to the previously applied cost reduction measures.

Moreover, GrowLife also posted a sales backlog of $1 million, scheduled to ship in the quarter to come.

“While others are pulling back due to the pandemic and other conditions, we are so happy to announce an up quarter,” said the company’s CEO Marco Hegyi.

GrowLife continued to operate throughout the current health crisis as an “essential service,” supplying hemp farmers and cannabis operators “during the pivotal spring season,” explained Hegyi.

“The fact that we are growing during these unprecedented times, speaks volumes to how we are positioned as a company,” added Hegyi.

Other quarterly highlights include:

  • Gross profit increased during the quarter to $0.7 million
  • Operating expenses declined by $1.7 million year-over-year
  • Net loss amounted to $610,523 versus a net loss of $1,376,996 in the corresponding quarter of 2019
  • Cash flow used in operations decreased to $905,804 over the year

Meantime, GrowLife made some leadership changes last month, as it appointed Lewis Swarts and Daniel Harder to its advisory board.

The board is focused on developing the company’s CBD-rich hemp cloning business.

Courtesy photo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.